Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Trial details
- Registry ID
- NCT05291091
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)NCT05291091 | EWTX | Phase 2 | Completed | 2026-09-07Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |